ABOUT US

Carticept Medical, Inc., located in Alpharetta, Georgia, was founded in 2005 by a group of medical device industry veterans.
Carticept, a private, venture capital-backed company, is dedicated to improving the quality of life for patients with osteoarthritis
or cartilage damage through the development of novel therapies.

An estimated 27 million Americans suffer from osteoarthritis, a chronic degenerative joint disease characterized by the breakdown
of the cartilage in the joint. An additional two million Americans injure the cartilage in their knees each year. Many people do
not respond well to current medical treatments or are not eligible for major surgery such as a total joint replacement. Carticept's
mission is to develop and market products to help physicians treat osteoarthritis and cartilage injuries and the related pain more effectively.

Our management team, board of directors and medical advisors are comprised of industry-recognized professionals who possess broad
knowledge in orthopedics and extensive experience managing innovative medical devices from development through clinical trials,
FDA approval and successful commercialization.